Skip to main navigation Skip to search Skip to main content

Project Details

Description

Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
StatusFinished
Effective start/end date12/1/155/31/18

Funding

  • NIH NATIONAL CANCER INSTITUTE

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.